SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
461 Open note to PARS shareholders: Many of you know I have taken an active intereAriella-2/5/1999
460 When BOL first rolled out Lotemax & Alrex, they only had 65 sales reps to cRick Strange-2/4/1999
459 An excellent Case Study on how focus can be lost and assets frittered crysball-2/4/1999
458 crysball, here is a "Scientists In The Candy Store" story for you: sRick Strange-2/4/1999
457 Ron,I share your reasons for staying long. If I wouldn't believe that PARS Richard Huth-2/4/1999
456 Food for thought! I ran into this article referenced on another thread. But it Dr. John M. de Castro-2/4/1999
455 Richard...thank you for telling from the heart. I share those same concerns asRon-2/4/1999
454 If one is interested how good PR with - for investors - bad news can look like,Richard Huth-2/4/1999
453 Dear Ron The answer to this decline is, in my view, very simple. As mentioned Richard Huth-2/4/1999
452 Hello Ron: I do not think that the company is in trouble I THINK that the proDavid Israel-Rosen-2/4/1999
451 Wow...Since I have not paid much attention to the daily stock price of our compRon-2/4/1999
450 Ariella: We Have been doing it for a while now !!! But as you can see from tDavid Israel-Rosen-2/3/1999
449 You'r right about tamoxifen being an analog of a blockbuster drug. LE-T is Rick Strange-2/3/1999
448 I think Rick has made a cogent comparison between the two companies. PARS reallRockDoc-2/3/1999
447 Rick -- I can always count on you to make exceptionally well-informed posts. YoAriella-2/3/1999
446 Thinking Caps Ariella, good thought, but Human and Organizaional Behavior crysball-2/3/1999
445 Ariella, Since I've been involved with both companies, I'll take a shoRick Strange-2/3/1999
444 More thinking cap work... 1) PARS specialty is rational drug design, as opposAriella-2/2/1999
443 Maybe we should take a lesson from the venture capitalists? <<February 2Ariella-2/2/1999
442 ShamukeE: Thanks for the short numbers. Appreciate it. Arniearnie h-2/1/1999
441 967,250....................4.17da.ShamukE-2/1/1999
440 Short Interest in PARS as of Jan 15, 1999: 967,250 as of 1/15/99 950,453 Ariella-1/31/1999
439 Pending News Releases form PARS One of my colleagues sent Gwen an email crysball-1/30/1999
438 Arnie- sorry about that- as you can tell, just copied without really looking atTony van Werkhooven-1/30/1999
437 Tony: Should be another one just now coming out giving the level as of late Janarnie h-1/30/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News